The FDA signed off on updated mRNA COVID-19 vaccines from Pfizer and Moderna. The new shots target the KP.2 strain and are expected to be available at pharmacies, hospitals and clinics within a few days, the drugmakers said.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
